Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	22.99	19.36	49.9	48.33	11.29
Cash & Cash Equivalents	22.99	19.36	49.9	48.33	11.29
Cash Growth	18.72%	-61.20%	3.24%	327.94%	58.79%
Receivables	28.94	21.71	28.18	5.63	1.74
Inventory	12	10.85	16.34	10	1.44
Other Current Assets	8.92	8.01	10.82	11.46	0.96
Total Current Assets	72.83	59.93	105.23	75.42	15.43
Property, Plant & Equipment	3.87	6.3	8.7	0.89	0.2
Long-Term Investments	0	0	0	0	0
Goodwill and Intangibles	58.97	70.63	151.27	76.95	19.08
Other Long-Term Assets	0.79	0.77	0.47	0.03	0
Total Long-Term Assets	63.63	77.69	160.43	77.87	19.29
Total Assets	136.46	137.62	265.67	153.29	34.72
Accounts Payable	13.48	10.99	19.26	11.64	2.13
Current Debt	1.65	3.91	24.6	1.28	0
Other Current Liabilities	53.89	49.55	65.58	15.84	3.24
Total Current Liabilities	69.02	64.44	109.44	28.76	5.37
Long-Term Debt	14.71	14.28	0.18	11.9	0
Other Long-Term Liabilities	13.38	14.59	18.48	17.62	22.26
Total Long-Term Liabilities	28.09	28.87	18.66	29.52	22.26
Total Liabilities	97.11	93.32	128.1	58.28	27.63
Total Debt	16.36	18.19	24.78	13.18	0
Debt Growth	-10.05%	-26.61%	88.04%	-	-
Retained Earnings	-304.13	-287.08	-178.3	-120.01	-106.39
Shareholders' Equity	39.36	44.31	137.57	95.02	7.09
Net Cash / Debt	6.62	1.17	25.12	35.15	11.29
Net Cash / Debt Growth	465.19%	-95.33%	-28.55%	211.26%	58.79%
Net Cash Per Share	1.98	0.80	30.00	155.58	289.80
Working Capital	3.82	-4.51	-4.2	46.66	10.06
Book Value Per Share	11.78	30.14	164.29	420.50	181.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).